BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37439554)

  • 1. Retracted: 14-3-3ζ promotes gliomas cells invasion by regulating Snail through the PI3K/AKT signaling.
    Cancer Med; 2023 Jul; 12(14):15761. PubMed ID: 37439554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction.
    Cancer Med; 2023 May; 12(9):11041. PubMed ID: 37050853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction.
    Cancer Med; 2023 Sep; 12(18):19352. PubMed ID: 37724781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction.
    Cancer Med; 2023 May; 12(9):11040. PubMed ID: 37046403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction.
    Cancer Med; 2023 Dec; 12(24):22437. PubMed ID: 38100296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction: Wang Y, Yue D. CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/β-catenin signaling pathway.
    Cancer Med; 2024 Apr; 13(7):e7138. PubMed ID: 38546000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction.
    Cancer Med; 2023 May; 12(10):12034. PubMed ID: 37097252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retraction: lncRNA HOTAIR promotes gastric cancer proliferation and metastasis via targeting miR-126 to active CXCR4 and RhoA signaling pathway.
    Cancer Med; 2024 May; 13(9):e7220. PubMed ID: 38695659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
    Asia Pac J Clin Oncol; 2023 Dec; 19(6):762. PubMed ID: 37888963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retraction.
    Cancer Sci; 2023 Jul; 114(7):3057. PubMed ID: 37211924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RETRACTION: Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma.
    Cancer Med; 2024 Jun; 13(11):e7338. PubMed ID: 38813651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction.
    J Cell Physiol; 2022 Mar; 237(3):2012. PubMed ID: 34287866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction.
    Int J Gynaecol Obstet; 2023 Aug; 162(2):784. PubMed ID: 37210671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction.
    J Cell Physiol; 2022 Mar; 237(3):2008. PubMed ID: 34287878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction.
    J Cell Physiol; 2022 Mar; 237(3):2004. PubMed ID: 34287884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction Statement.
    Int J Clin Pract; 2021 Dec; 75(12):e14925. PubMed ID: 34636464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction: lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2.
    Cancer Med; 2024 Mar; 13(5):e7098. PubMed ID: 38470371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction.
    J Cell Biochem; 2021 Nov; 122 Suppl 1():S102. PubMed ID: 34288045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction.
    Int J Gynaecol Obstet; 2023 Sep; 162(3):1127. PubMed ID: 37358060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction: Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway. Li-Li Wang, Wei-Wei Huang, Jing Huang, Rong-Fang Huang, Na-Ni Li, Yi Hong, Mu-Lan Chen, Fan Wu, Jian Liu, Kaohsiung J Med Sci. 2020; 36(8): 581-591 (https://doi.org/10.1002/kjm2.12212).
    Kaohsiung J Med Sci; 2023 Dec; ():. PubMed ID: 38088487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.